Atlas Trials

Inhaled Amikacin in Preventing AECOPD

Clinical trial NCT05213507 · UNKNOWN

Trial details

NCT number
NCT05213507
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COPDCOPD Exacerbation
Start date
2022-03-01
Primary completion
2023-12-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.